Attached files

file filename
EX-32.2 - SECTION 906 CFO CERTIFICATION - Sabra Health Care REIT, Inc.sbraex3222018q2.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - Sabra Health Care REIT, Inc.sbraex3212018q2.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Sabra Health Care REIT, Inc.sbraex3122018q2.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Sabra Health Care REIT, Inc.sbraex3112018q2.htm
10-Q - 10-Q - Sabra Health Care REIT, Inc.sbra10q2018q2.htm
Exhibit 12.1



SABRA HEALTH CARE REIT, INC. AND SUBSIDIARIES
COMPUTATION OF RATIOS OF EARNINGS TO COMBINED FIXED CHARGES
AND PREFERRED STOCK DIVIDENDS
(dollars in thousands)

 
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
 
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
 
 
Earnings
 
 
 
 
 
 
 
 
 
Income before loss from unconsolidated joint venture and income tax expense
 
$
203,741

 
$
20,672

 
$
266,286

 
$
39,683

 
Add:
 
 
 
 
 
 
 
 
 
Fixed charges
 
36,811

 
15,878

 
72,683

 
31,682

 
Noncontrolling interests
 
(2
)
 
(16
)
 
(12
)
 
16

Earnings, as adjusted
 
$
240,550

 
$
36,534

 
$
338,957

 
$
71,381

 
 
 
 
 
 
 
 
 
 
Fixed charges
 
 
 
 
 
 
 
 
 
Interest expensed and capitalized
 
$
34,241

 
$
14,209

 
$
67,578

 
$
28,406

 
Non-cash interest expense
 
2,516

 
1,653

 
4,997

 
3,244

 
Estimate of interest within rental expense
 
54

 
16

 
108

 
32

Fixed charges, as adjusted
 
36,811

 
15,878

 
72,683

 
31,682

Preferred stock dividends (1)
 
1,706

 
2,560

 
4,267

 
5,121

Combined fixed charges and preferred stock dividends
 
$
38,517

 
$
18,438

 
$
76,950

 
$
36,803

 
 
 
 
 
 
 
 
 
 
Ratio of earnings to fixed charges
 
6.53
x
 
2.30
x
 
4.66
x
 
2.25
x
 
 
 
 
 
 
 
 
 
 
Ratio of earnings to combined fixed charges and preferred stock dividends
 
6.25
x
 
1.98
x
 
4.40
x
 
1.94
x
(1) 
The three and six months ended June 30, 2018 exclude $5.5 million of capitalized issuance costs related to the preferred stock issuance that were written off as a result of the June 1, 2018 preferred stock redemption and presented as an additional preferred stock dividend in the condensed consolidated statements of income of Sabra Health Care REIT, Inc.